This is further emphasized by the reactivation of the CLU gene by all the G9a inhibitors shown in our studies, as it is a NB tumor suppressor gene known to be regulated by EZH2 and MYCN (10, 11, 34). The gene discussed is EZH2; the disease is neuroblastoma.